Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01545362Completed

Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Arthroplasty

Role: lead

NCT01527968Not ApplicableUnknown

Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty

Role: lead

NCT01132365Unknown

Knee Arthroplasty Registry

Role: lead

NCT01133249Unknown

Total Hip Registry

Role: lead

NCT01132378Not ApplicableCompleted

Midvastus Versus Medial Parapatellar Approach for Minimally Invasive Total Knee Arthroplasty

Role: lead

NCT01135030Not ApplicableCompleted

Anterior Referencing Versus Posterior Referencing in Minimally Invasive Total Knee Arthroplasty

Role: lead

All 6 trials loaded